The Pennant Group, Inc. PNTG

40.77 1.14 2.88% as of 25 Sep
Market cap
$1.4B
P/E
43.4×
Growth Flags show if company had growth for consecutive years

Insider Decisions

Total sells 0.69
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — 1 — 2 3 —
Insider Ownership 4.75%

Capital & Financial Ratios

Market Cap 1,380.00
Revenue 1,101.71
Net Income 38.45
Free Cash Flow 34.68
Net Debt 182.23
Current Ratio 1.20
Debt/Equity 0.49
P/E ratio 43.37
P/S ratio 1.29
P/B ratio 3.51
Past 5Y EPS Growth 52.31%
This Y EPS Growth 18.28%
Next Y EPS Growth 13.51%
Next 5Y EPS Growth 16.07%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2018 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 6 24 17 15
Receivables 61 81 123 133
Inventory — — — —
Other — — — —
80 123 167 184
2023 2024 2025 Q'26
Payables 11 19 25 26
ST’ Debt — — 5 5
Other — — — —
72 102 147 152
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — 19.37% 26.05%
Cash Flow — (0.77%) 74.79%
Earnings — 13.44% 64.51%
Book Value — 29.90% 43.88%

Revenue

Mar Jun Sep Dec Year
’26 285 298 — — —
’25 210 220 229 289 948
’24 157 169 181 189 695
’23 126 132 140 146 545
’22 114 116 118 125 473
’21 106 110 112 112 440
’20 92 93 98 108 391
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (3) 22 — — —
’25 (21) 35 14 21 48
’24 1 10 8 21 39
’23 9 7 12 5 33
’22 (4) 9 8 (4) 9
’21 (7) (5) (1) (5) (18)
’20 2 41 10 (3) 50
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (9) 15 — — —
’25 (23) 32 10 17 36
’24 (3) 9 7 17 30
’23 7 5 11 3 25
’22 (6) 3 6 (8) (5)
’21 (8) (6) (3) (7) (25)
’20 (1) 38 8 (2) 43
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.24 0.25 — — —
’25 0.22 0.20 0.17 0.24 0.84
’24 0.16 0.18 0.20 0.16 0.70
’23 0.06 0.09 0.15 0.14 0.44
’22 0.03 (0.09) 0.16 0.12 0.22
’21 0.03 0.09 0.04 (0.08) 0.09
’20 0.10 0.15 0.15 0.13 0.52
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — 6.15 9.40 17.52 8.68 10.00 13.77 21.18

Analyst estimates 2026–2028

Powerpack
Low Price
— — — 35.99 66.62 69.56 24.23 16.39 37.13 30.46
High Price
— — — — 5,223 6,441 5,335 5,791 7,000 9,700
Employees
0 0 0 0 0 0 0 0 0 0
Revenue/Emp
217 251 286 339 391 440 473 545 695 948
Revenue
11.71% 12.91% 14.84% 13.18% 14.04% 11.05% 12.38% 12.30% 13.49% 13.77%
Gross Margin
13 15 21 5 18 3 9 20 31 46
EBT
5.98% 6.14% 7.21% 1.55% 4.58% 0.62% 1.88% 3.59% 4.51% 4.81%
EBT Margin
8 10 16 3 16 2 7 14 24 34
Net Income
3 3 3 4 5 5 5 6 7 9
Depreciation
7.76 9.02 10.28 12.16 13.95 15.48 16.28 18.25 22.29 27.42
Revenue/Sh
0.28 0.36 0.58 0.11 0.56 0.09 0.23 0.45 0.72 0.86
Earnings/Sh
0.59 0.62 0.84 0.34 1.79 (0.64) 0.31 1.11 1.26 1.40
Cash Flow/Sh
0.00 (0.09) (0.13) (0.24) (0.26) (0.22) (0.49) (0.27) (0.29) (0.35)
Capex/Sh
0.59 0.53 0.71 0.10 1.53 (0.86) (0.18) 0.84 0.97 1.05
Free CF/Sh
0.00 0.00 2.35 2.55 3.61 4.02 4.32 4.87 10.00 10.83
Book Value/Sh
28 28 28 28 28 28 29 30 31 35
Shares
37.31 37.31 37.31 312.57 101.86 288.50 46.87 31.56 36.83 32.36
PE Ratio
1.30 1.30 1.30 2.72 4.16 1.49 0.66 0.78 1.19 1.03
PS Ratio
4.98 4.98 4.98 12.95 16.09 5.74 2.49 2.91 2.65 2.60
PB Ratio
2.05 2.05 2.05 2.81 4.22 1.63 0.83 0.91 1.54 1.19
EV/Sales
47.09 47.09 47.09 334.86 38.41 (29.27) (76.23) 19.94 35.40 31.16
EV/FCF
16 17 23 10 50 (18) 9 33 39 48
Op' Cash Flow
(3) (3) (4) (7) (7) (6) (14) (8) (9) (12)
Capex
16 15 20 3 43 (25) (5) 25 30 36
FCF
— 0 0 (13) (29) 4 4 9 21 20
Working Cap'
— — — 31 22 67 80 64 — 174
Total Debt
— 0 0 30 22 62 77 58 (24) 157
Net Debt
— 0 65 71 101 114 126 146 312 374
Sh' Equity
0.00% 10.58% 31.96% 0.93% 3.30% 0.52% 1.27% 2.54% 3.70% 3.59%
ROA
— 0.00% 19.76% 3.49% 9.57% 1.66% 3.92% 7.73% 8.28% 6.11%
ROIC
0.00% 17.80% 26.08% 3.73% 18.28% 2.50% 5.54% 9.87% 9.86% 8.62%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

The Pennant Group, Inc. (PNTG) key facts

  • The Pennant Group, Inc. (PNTG) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
  • Net income was $33.8 million, or $0.86 per share (basic), a net margin of 3.12%.
  • As of September 25, 2026, PNTG traded at $40.77, a market capitalization of $1.4 billion.
  • At that price the stock trades at 43.4× trailing-twelve-month earnings and 1.3× sales.
  • Return on equity was 8.62% and debt-to-equity 0.49.

Source: company filings (standardised) and stockrow calculations.

The Pennant Group, Inc. (PNTG) Latest News

News by impact score

Fine-tune

25 Sep

4

Pennant Group (PNTG) has acquired Mainplace Senior Living's real estate in Orange, California, converting the community from a triple-net leased asset to company-owned property. The move expands Pennant's owned real estate footprint and aligns with its disciplined capital-allocation approach, aiming to improve control over capital projects, occupancy mix, and long-term planning. The purchase introduces balance-sheet considerations and potential leverage changes depending on financing. Investors are urged to weigh the impact against Pennant's broader business narrative while awaiting disclosure of the purchase price and financing terms; future quarters will reveal effects on occupancy and segment earnings within the 2026 revenue guidance. The move is described as a meaningful step to support reinvestment capacity, with debt-risk cautions tied to financing choices. Shifting from lease to owned real estate alters balance-sheet dynamics and leverage risk, potentially expanding reinvestment capacity and long-term cash-flow implications.

24 Sep

4

Pennant Group (PNTG) is named a 'Two Growth Stocks to Sell' pick despite 37.6% one-year revenue growth. It has a small base of about $1.09 billion, a weak five-year free cash flow margin of 2.4%, and a high net debt-to-EBITDA of 6x, which could force capital raises in downturns. Trading at $40.45 with a forward P/E of 26.6x, the spun-off Ensign Group unit focuses on home health, hospice, and senior living across 13 states. The piece contrasts it with Flutter Entertainment and Waters Corp, but concludes there are better opportunities than PNTG. High net debt-to-EBITDA (6x) and a slim free cash flow margin raise funding risk, potentially pressuring growth and valuation.

21 Sep

3

The Pennant Group, Inc. (PNTG) shows a Momentum Style Score of B and a Zacks Rank of #2 (Buy). Short-term momentum is positive: shares up 1.07% over the last week, 1.9% over the past month, and 10.33% in the last quarter, with a 64.26% gain year over year. The industry (Medical - Outpatient and Home Healthcare) is flat over the same period. Volume remains solid, averaging about 351k shares over 20 days. Earnings revisions have trended higher: two revisions up for the current year (from 1.35 to 1.39) and two upward revisions for the next fiscal year, with no downward revisions. These factors align with a potential near-term upside and reinforce a Buy stance. Momentum scores and upward revisions point to a moderate near-term upside.

16 Sep

3

Pennant Group acquires real estate of Mainplace Senior Living facility in Orange, California. Acquisition expands Pennant Group's senior living real estate holdings with one new location.

14 Sep

3

The Pennant Group (PNTG) rating has been upgraded to Buy. Analyst upgrade to Buy rating can lift near-term investor sentiment and trading activity for PNTG.

4 Sep

3

Benchmarking of The Pennant Group (PNTG) Q2 results positions the company within senior health, home health and hospice stocks against sector peers. Q2 benchmarking provides competitive positioning data that can moderately shift market views on PNTG financial performance.

2 Sep

3

Ensign Group's operating model faces questions over sustaining growth without acquisitions, with direct implications for The Pennant Group Inc.'s trajectory. Ensign's acquisition-independent growth approach may moderately shape Pennant Group's competitive positioning and performance outlook.

19 Aug

3

The Pennant Group, Inc. faces legal risks yet receives a buy rating from analysts. Legal risks introduce moderate uncertainty for The Pennant Group while the buy rating supports ongoing market confidence without major trajectory shifts.

7 Aug

4

Pennant Group beat Q2 earnings expectations, raised full-year guidance and completed a new acquisition, all positive developments for shareholders. Q2 earnings beat combined with raised guidance and new acquisition point to stronger financial trajectory and growth outlook.

3 transcript

Pennant Group reported Q2 results with revenue and operational updates during its earnings call, covering financial performance and segment highlights. Q2 earnings highlights supply financial metrics that moderately influence performance outlook and investor sentiment.

6 Aug

4

Pennant Group Inc reported strong Q2 2026 revenue growth in its earnings call and raised its outlook. Strong revenue growth combined with raised guidance signals major positive shifts in financial trajectory and investor sentiment.

5 Aug

4

The Pennant Group, Inc. reported its second quarter 2026 financial results. Quarterly earnings directly drive stock valuation and investor sentiment for Pennant Group.

3

The Pennant Group, Inc. beat Q2 earnings and revenue estimates. Q2 earnings and revenue beat typically supports short-term stock gains and positive sentiment without altering long-term fundamentals.

3

Pennant Group reported strong Q2 CY2026 results with a full-year outlook that slightly exceeds expectations. Strong quarterly numbers and modestly better annual guidance can move near-term stock sentiment without fundamentally shifting long-term trajectory.

4 Aug

3

Rapid growth at The Pennant Group collides with premium valuation, raising questions whether BTSG represents a buy. Growth-valuation tension may moderately sway investor sentiment and near-term stock moves without altering core trajectory.

14 Jul

3

Pennant Group insider sold shares as the company's home health revenue surged 43%. 43% home health revenue growth supports stronger future results while single insider sale has limited offsetting effect.

6 Jun

4

Pennant Group expands partnership with Hartford HealthCare, prompting updated valuation assessment for PNTG shares based on enhanced operational reach and revenue potential. Expanded Hartford HealthCare partnership strengthens Pennant Group's market position and growth prospects.

3

Pennant Group executes new deals to expand senior and home care operations, testing its growth ambitions amid sector competition. New deals signal strategic expansion that may moderately shift financial performance and positioning without guaranteed transformation.

4 Jun

3

The Pennant Group and Hartford HealthCare expand collaboration to advance home-based care in Connecticut. Expanded Hartford HealthCare collaboration directly grows Pennant Group's Connecticut home-based care operations and regional revenue potential.

18 May

3

The Pennant Group (PNTG) offers three key reasons for growth investors to consider the stock based on its market potential and operational strengths. Positive investor-focused coverage may moderately lift sentiment and near-term trading interest in PNTG shares.

16 May

3

Pennant Group's Q1 earnings call drew analyst questions on expansion plans, margin pressures, reimbursement trends, acquisition integration, and 2024 growth targets. Analyst questions in earnings calls often shape short-term investor views on financial outlook and strategy.

8 May

4

The Pennant Group, Inc. (PNTG) Q1 earnings call highlights key financial results, revenue growth, operational updates, and forward guidance for home health and hospice services. Q1 earnings highlights detail financial performance and guidance, likely driving significant shifts in investor sentiment and stock trajectory.

7 May

4 transcript

Pennant Group, Inc. (PNTG) released Q1 2026 earnings call transcript detailing first-quarter financial results, operational updates, and management's outlook. Q1 2026 earnings transcript discloses financial performance, guidance, and strategic insights that could significantly shape PNTG's market trajectory and investor sentiment.

4

The Pennant Group, Inc. (PNTG) released Q1 2026 earnings call summary, detailing financial results, operational performance, and future outlook. Quarterly earnings call summaries reveal financial metrics and guidance that significantly shape investor expectations and stock trajectory.

6 May

4

The Pennant Group, Inc. (PNTG) Q1 earnings and revenues exceeded analyst estimates. Beating Q1 earnings and revenue estimates boosts investor confidence and signals strong operational performance for future growth.

4

The Pennant Group (NASDAQ:PNTG) reported surprising Q1 CY2026 sales, exceeding market expectations and signaling strong performance. Q1 sales surprise represents major financial outperformance poised to enhance investor sentiment and stock trajectory.

4

The Pennant Group, Inc. (PNTG) reported first quarter 2026 results, highlighting key financial metrics and operational performance. Quarterly earnings releases reveal financial health and operational metrics that significantly sway investor sentiment and stock trajectory.

3 May

4

Pennant Group (PNTG) expands senior living operations by 194 units, positioning the company for revenue growth and enhanced shareholder value in a high-demand sector. 194-unit senior living expansion constitutes a major strategic move to capture market growth and improve long-term financial performance.

1 May

4

The Pennant Group, Inc. (PNTG) acquires senior living communities in Arizona and Wisconsin. Acquisition expands Pennant's senior living portfolio across two states, driving revenue growth and strengthening market position.

3 Apr

3

Q4 winners and losers analysis compares The Pennant Group (PNTG) to peers in senior health, home health, and hospice stocks. PNTG's Q4 performance ranking versus sector peers moderately influences financial perception and market sentiment.

stockrow.com/PNTG · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com